pamidronate has been researched along with calcitriol in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.16) | 18.7374 |
1990's | 21 (42.86) | 18.2507 |
2000's | 18 (36.73) | 29.6817 |
2010's | 6 (12.24) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barto, R; Hackeng, WH; Leeuwenkamp, OR; Lips, P; Netelenbos, JC; van der Vijgh, WJ; van der Wiel, H; van Ginkel, FC | 1 |
Hoekman, K; Papapoulos, SE; Tjandra, YI | 1 |
Reid, IR; Schooler, BA; Stewart, AW | 1 |
Boland, B; Devogelaer, JP; Godfraind, C; Lambert, M; Nagant de Deuxchaisnes, C; Noel, H | 1 |
Dandona, P; Khokher, MA | 1 |
Bijvoet, OL; Hoekman, K; Papapoulos, SE; Peters, AC | 1 |
Garba, MT; Hott, M; Marie, PJ | 1 |
Adami, S; Bijvoet, OL; Clemens, TL; Frijlink, WB; O'Riordan, JL; Papapoulos, SE | 1 |
Algra, D; Erdtsieck, RJ; Lamberts, SW; Pols, HA; Valk, NK | 1 |
Demura, H; Imaki, T; Kasajima, T; Kobayashi, T; Sato, K; Takeuchi, A; Tanaka, M; Toraya, S | 1 |
Ammann, P; Bonjour, JP; Budayr, AA; Burckhardt, P; Gertz, B; Jaquet-Müller, F; Jenzer, A; Rizzoli, R; Thiébaud, D; Zysset, E | 1 |
Devlin, RD; Fenton, AJ; Grill, V; Gutteridge, DH; Kent, GN; Prince, RL; Retallack, RW; Worth, GK | 1 |
Harada, K; Inaba, M; Ishimura, E; Koyama, H; Miki, T; Morii, H; Nakatsuka, K; Nishizawa, Y | 1 |
Brossard, JH; D'Amour, P; Garon, J; Gascon-Barré, M; Lepage, R | 1 |
Chen, T; Greenspan, SL; Gundberg, C; Holick, M; Kung, VT; Moses, AC; Rosen, HN; Seyedin, SM | 1 |
Body, JJ; Dumon, JC; Ford, J; Piccart, M | 1 |
Powers, K; Tal, A | 1 |
Cantagrel, A; Laroche, M; Mazieres, B; Moulinier, L; Redon-Dumolard, A | 1 |
Hartzband, P; Lally, M; Sakoulas, G; Tritos, NA; Wanke, C | 1 |
Del Campo, MT; Gijón, J; Martínez, ME; Plaza, MA; Torrijos, A | 1 |
Endo, K; Fujita, T; Iguchi, H; Ikeda, K; Katsumata, K; Kubodera, N; Ogata, E; Teramoto, T | 1 |
Addesso, V; Lo, SH; Mancini, D; McMahon, DJ; Michler, RE; Rodino, MA; Seibel, MJ; Shane, E; Staron, RB | 1 |
Bhagat, CI; Dhaliwal, SS; Gutteridge, DH; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Ward, L | 1 |
Felsenfeld, AJ; Jara, A; Kleeman, CR; Lee, E; Moatamed, F; Stauber, D | 1 |
Holbert, JM; Imseis, RE; Leventhal, MR; Palmieri, GM; Sebes, JI | 1 |
Bianda, T; Brunner, H; Junga, G; Kiowski, W; Linka, A; Schmid, C; Steinert, H | 1 |
Avedian, G; Felsenfeld, AJ; Jara, A; Kleeman, CR | 1 |
Mechanick, JI; Nierman, DM | 1 |
Chung, SS; Huh, K; Kim, KR; Kim, SI; Lee, HC; Lim, SK; Moon, JI; Nam, JH; Park, KI; Song, YD | 1 |
Fallon, MA; Finkelstein, JS; Leder, BZ; Lee, ML; Smith, MR | 1 |
Gutteridge, DH; Kent, GN; Lim, EM; Stuckey, BG; Ward, LC | 1 |
Chen, B; Mechanick, JI; Nierman, DM; Stein, A | 1 |
Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
Goga, T; Hishida, A; Kato, A; Shinozaki, S | 1 |
Arsura, EL; Caldwell, JW; Johnson, RH; Kilgore, WB; Reddy, CM | 1 |
Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R | 1 |
Chapurlat, RD; Delmas, PD; Hugueny, P; Meunier, PJ | 1 |
An, H; Andersson, GB; Chandrasekaran, R; Dobai, JG; Galante, JO; Glant, TT; Hallab, NJ; Jacobs, JJ; Vermes, C | 1 |
Glorieux, FH; Munns, C; Rauch, F; Travers, R; Zeitlin, L | 1 |
Cull, G; Henley, D; Kaye, J; Walsh, J | 1 |
Brown, JJ; Zacharin, MR | 1 |
Berrut, G; Foussard, C; Frein, D; Josselin, N; Lavigne, C; Moles, MP; Sivova, N | 1 |
Richardson, M; Spruill, L; Sullivan, S; Tarnawa, E; Underwood, P | 1 |
Ammann, P; Brennan, TC; Dayer, R; Dubois-Ferrière, V; Rizzoli, R | 1 |
Chu, P; Huang, CY; Lo, L; Lu, KC; Wu, CC; Zheng, CM | 1 |
Geesing, CL; Hoenderop, JG; Lameris, AL; Schreuder, MF | 1 |
Jain, N; Reilly, RF | 1 |
4 review(s) available for pamidronate and calcitriol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.
Topics: Aged; Calcitriol; Cataract; Diphosphonates; Female; Glucocorticoids; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Pamidronate | 1990 |
Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.
Topics: Calcitriol; Calcium, Dietary; Child, Preschool; Diphosphonates; Female; Gene Deletion; Humans; Hypercalcemia; Infant; Infant, Newborn, Diseases; Intestinal Absorption; Metabolism, Inborn Errors; Pamidronate; Transcription Factors; Williams Syndrome | 2014 |
Hungry bone syndrome.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Diphosphonates; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Pamidronate; Parathyroidectomy; Renal Dialysis; Syndrome | 2017 |
10 trial(s) available for pamidronate and calcitriol
Article | Year |
---|---|
Prevention of glucocorticoid-induced osteoporosis.
Topics: Adult; Alkaline Phosphatase; Calcitriol; Clinical Trials as Topic; Diphosphonates; Female; Glucocorticoids; Humans; Hydroxyproline; Male; Middle Aged; Osteocalcin; Osteoporosis; Pamidronate; Prospective Studies | 1990 |
Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.
Topics: Adolescent; Adult; Amino Acids; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteocalcin; Pamidronate; Parathyroid Hormone; Triiodothyronine | 1993 |
Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.
Topics: Adult; Aged; Analysis of Variance; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitriol; Calcium; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hydroxyproline; Infusions, Intravenous; Middle Aged; Osteolysis; Pamidronate; Parathyroid Hormone | 1995 |
Pamidronate and biochemical markers of bone turnover.
Topics: Acid Phosphatase; Adult; Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; Diphosphonates; Female; Humans; Injections, Intravenous; Isoenzymes; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Pamidronate; Tartrate-Resistant Acid Phosphatase | 1997 |
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density; Calcitriol; Calcium, Dietary; Diphosphonates; Forearm; Humans; Injections, Intravenous; Middle Aged; Osteitis Deformans; Osteoporosis; Pamidronate; Parathyroid Hormone; Time Factors | 1999 |
Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Topics: Absorptiometry, Photon; Administration, Intranasal; Administration, Oral; Adult; Aged; Amino Acids; Anti-Inflammatory Agents; Biomarkers; Bone and Bones; Bone Density; Calcitonin; Calcitriol; Calcium; Calcium Channel Agonists; Diphosphonates; Female; Femur; Heart Transplantation; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Pamidronate | 2000 |
Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation.
Topics: Adult; Bone Density; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Female; Humans; Kidney Transplantation; Male; Middle Aged; Pamidronate; Postoperative Complications | 2000 |
Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Calcitriol; Calcium; Collagen; Collagen Type I; Diphosphonates; Humans; Hypogonadism; Leuprolide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Osteocalcin; Pamidronate; Peptides; Prostatic Neoplasms; Teriparatide; Time Factors | 2001 |
Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
Topics: Adolescent; Adult; Bone Density Conservation Agents; Calcitriol; Calcium; Child; Dietary Supplements; Diphosphonates; Female; Glucocorticoids; Humans; Male; Osteoporosis; Pamidronate; Victoria | 2005 |
Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Topics: Anti-Inflammatory Agents; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Channel Agonists; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Postmenopause; Renal Dialysis; Treatment Outcome | 2012 |
35 other study(ies) available for pamidronate and calcitriol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Alkaline Phosphatase; Bone and Bones; Bone Development; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Kinetics; Male; Osteocalcin; Pamidronate; Phosphates | 1991 |
The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein.
Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ovarian Neoplasms; Pamidronate; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone-Related Protein; Proteins | 1991 |
Diphosphonates inhibit human osteoblast secretion and proliferation.
Topics: Alkaline Phosphatase; Calcitriol; Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Kinetics; Osteoblasts; Pamidronate; Thymidine | 1989 |
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis.
Topics: Adolescent; Calcitriol; Calcium; Diphosphonates; Humans; Hydroxyproline; Intestinal Absorption; Male; Osteoporosis; Pamidronate; Parathyroid Hormone; Radiography; Wrist | 1985 |
Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Development; Bone Matrix; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Growth; Male; Mice; Pamidronate; Phosphates | 1985 |
Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Humans; Hypocalcemia; Middle Aged; Osteitis Deformans; Osteoporosis; Pamidronate; Parathyroid Hormone | 1982 |
Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass.
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Bone Density; Calcitriol; Diphosphonates; Drug Therapy, Combination; Female; Forearm; Growth Hormone; Humans; Kidney; Lumbar Vertebrae; Male; Middle Aged; Pamidronate; Phosphates | 1995 |
Increased 1,25-(OH)2D2 concentration in a patient with malignancy-associated hypercalcemia receiving intravenous hyperalimentation inadvertently supplemented with vitamin D2.
Topics: Calcitriol; Contraindications; Diphosphonates; Ergocalciferols; Humans; Hypercalcemia; Male; Middle Aged; Neoplasm Proteins; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parenteral Nutrition, Total; Protein Biosynthesis; Stomach Neoplasms | 1993 |
Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Topics: Alendronate; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypercalcemia; Male; Neoplasms; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Phosphorus; Proteins | 1994 |
Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Parathyroid Hormone; Reference Values | 1994 |
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Topics: Adenoma; Adult; Alkaline Phosphatase; Bone and Bones; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Parathyroid Neoplasms; Phosphates | 1993 |
Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Topics: Adenoma; Alkaline Phosphatase; Bone Resorption; Calcitonin; Calcitriol; Calcium; Calcium Carbonate; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney; Middle Aged; Osteitis Fibrosa Cystica; Pamidronate; Parathyroid Hormone; Parathyroid Neoplasms | 1993 |
Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism.
Topics: Aged; Anti-Inflammatory Agents; Calcitriol; Calcium Carbonate; Diphosphonates; Emergencies; Female; Humans; Hydrocortisone; Hypercalcemia; Hypoparathyroidism; Pamidronate | 1996 |
Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate.
Topics: Adult; Aged; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypophosphatemia, Familial; Male; Middle Aged; Osteocalcin; Pamidronate; Parathyroid Hormone; Phosphates; Prospective Studies; Reflex Sympathetic Dystrophy | 1997 |
Hypercalcemia in an AIDS patient treated with growth hormone.
Topics: Acquired Immunodeficiency Syndrome; Adult; Calcium; Diphosphonates; Growth Hormone; HIV Wasting Syndrome; Humans; Hypercalcemia; Male; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Vitamin D | 1997 |
Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Calcitriol; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Drug Synergism; Humans; Hypercalcemia; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pamidronate; Pancreatic Neoplasms; Parathyroid Hormone-Related Protein; Pharyngeal Neoplasms; Proteins | 1998 |
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Hormone; Pilot Projects; Vitamin D | 1998 |
Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Calcitriol; Calcium; Creatinine; Diphosphonates; Food Deprivation; Male; Pamidronate; Parathyroid Hormone; Phosphates; Rats; Rats, Wistar; Time Factors | 1999 |
Effect of calcitriol and pamidronate in multiple myeloma.
Topics: Antineoplastic Agents; Bone Density; Bone Remodeling; Calcitriol; Calcium Channel Agonists; Diphosphonates; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pamidronate | 1999 |
Effects of fasting, feeding, and bisphosphonate administration on serum calcitriol levels in phosphate-deprived rats.
Topics: Animals; Antineoplastic Agents; Calcitriol; Calcium; Diphosphonates; Eating; Fasting; Hypercalcemia; Male; Pamidronate; Parathyroid Hormone; Phosphates; Phosphorus, Dietary; Rats; Rats, Wistar | 2000 |
Biochemical response to treatment of bone hyperresorption in chronically critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biomarkers; Calcitriol; Calcium; Calcium Channel Agonists; Chronic Disease; Collagen; Collagen Type I; Creatinine; Critical Illness; Diphosphonates; Female; Humans; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Hormone; Peptides; Respiratory Care Units; Retrospective Studies; Vitamin D Deficiency | 2000 |
Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
Topics: Alendronate; Calcitriol; Calcium; Cervical Vertebrae; Diphosphonates; Female; Humans; Hypocalcemia; Hypoparathyroidism; Middle Aged; Osteitis Deformans; Pamidronate; Pelvis; Scapula; Tibia; Time Factors; Treatment Outcome | 2001 |
Combined calcitriol-pamidronate therapy for bone hyperresorption in spinal cord injury.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bone Remodeling; Bone Resorption; Calcitriol; Calcium; Calcium Carbonate; Collagen; Collagen Type I; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pamidronate; Peptides; Spinal Cord Injuries | 2001 |
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Calcitriol; Corticotropin-Releasing Hormone; Diphosphonates; Female; Glomerulonephritis; Humans; Hydrocortisone; Hypercalcemia; Hypoparathyroidism; Pamidronate; Renal Dialysis | 2003 |
Hypercalcemia in patients with disseminated coccidioidomycosis.
Topics: Adult; Aged; Calcium; Coccidioidomycosis; Diphosphonates; Etidronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Retrospective Studies; Vitamin D | 2004 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome | 2004 |
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.
Topics: Administration, Oral; Adolescent; Adult; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcitriol; Calcium, Dietary; Child; Child, Preschool; Diphosphonates; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Humans; Infant; Infusions, Intravenous; Male; Middle Aged; Pain; Pamidronate; Phosphates; Prospective Studies; Radiography; Vitamin D | 2004 |
The combination of pamidronate and calcitriol reverses particle- and TNF-alpha-induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotype.
Topics: Adult; Aged; Alkaline Phosphatase; Calcitriol; Cell Division; Cell Survival; Cells, Cultured; Diphosphonates; Drug Combinations; Female; Humans; Interleukin-6; Male; Middle Aged; Osteoblasts; Osteonectin; Pamidronate; Procollagen; RNA, Messenger; Stromal Cells; Titanium; Tumor Necrosis Factor-alpha | 2004 |
The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.
Topics: Adolescent; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Calcium; Canada; Child; Child, Preschool; Diphosphonates; Female; Humans; Infant; Injections, Intravenous; Male; Osteogenesis Imperfecta; Pamidronate; Parathyroid Hormone; Phosphates; Retrospective Studies; Vitamin D | 2006 |
Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Topics: Acute Kidney Injury; Aged; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Diphosphonates; Fatal Outcome; Female; Humans; Hypocalcemia; Imidazoles; Injections, Intravenous; Magnesium Deficiency; Male; Middle Aged; Multiple Myeloma; Pamidronate; Zoledronic Acid | 2005 |
[Hypercalcaemia and malignant lymphoma. One case report].
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcitriol; Diphosphonates; Glucocorticoids; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Palliative Care; Pamidronate; Prednisone; Testicular Neoplasms | 2007 |
Severe hypercalcemia associated with uterine leiomyoma in pregnancy.
Topics: Adult; Calcitriol; Calcium; Critical Care; Diphosphonates; Female; Gynecologic Surgical Procedures; Humans; Hypercalcemia; Infant, Newborn; Leiomyoma; Pamidronate; Parathyroid Hormone-Related Protein; Pregnancy; Pregnancy Complications, Neoplastic; Severity of Illness Index; Treatment Outcome; Uterine Neoplasms | 2011 |
Calcitropic hormones and IGF-I are influenced by dietary protein.
Topics: Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Caseins; Dietary Proteins; Diphosphonates; Dose-Response Relationship, Drug; Female; Hyperparathyroidism; Immunoassay; Insulin-Like Growth Factor I; Lumbar Vertebrae; Pamidronate; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Time Factors; Vitamin D | 2011 |